Carol A Barnes | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Carol A Barnes

Sort by

Viewing results 1‒25 of 4412

WPP PLC
Ogilvy forms health influencer unit to target ‘new frontier’ in marketing
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
April 23, 2024
Travel & leisure industry
CitizenM owners explore potential sale of hotel group
...GIC took a 25 per cent stake in CitizenM five years ago in a deal that valued the business at €2bn including debt....
March 27, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Entain PLC
Entain examines possible sale of overseas gambling brands
...A sharper focus on operations is a crucial part of efforts by activist investors to put the gambling group in a position where it could ultimately be sold or broken up....
March 14, 2024
Abrdn Plc
Abrdn looks to scale back Bloomberg terminal access in cost-cutting drive
...A small number of people in equities are trialling a rival offering from US data and software company FactSet, which costs about a third of the price, one of the people said....
February 9, 2024
Biotech
Healthcare investor looks to cash in on pharma outsourcing trend with €1bn-plus sale
...the sale if a buyer is found....
March 3, 2024
Live news: EU votes to leave treaty seen as protecting fossil fuels
Biogen beats profit expectations but Alzheimer’s drug sales lag behind
...Biogen posted higher than expected profits in the first quarter as a $1bn cost-cutting drive began to pay off, but sales of its novel Alzheimer’s drug Leqembi lagged behind expectations....
April 24, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Live news: Chevron earnings beat expectations despite falling gas prices
US regulators approve Pfizer’s gene therapy for rare blood clotting disorder
...Pfizer is gearing up to launch its first-ever gene therapy at a list price of $3.5mn, after US regulators approved the treatment for a rare blood clotting disorder on Friday....
April 26, 2024
Live news: US secretly ships long-range missiles to Ukraine
Bernie Sanders to lead US Senate probe of Ozempic’s ‘outrageously high prices’
...A US senate committee chaired by Bernie Sanders has launched an investigation into the steep prices charged by Novo Nordisk for its blockbuster diabetes and anti-obesity medications Ozempic and Wegovy....
April 24, 2024
Pharmaceuticals sector
Pharma groups warn of supply crunch over China spying law
...A spokesperson for China’s Ministry of Foreign Affairs said: “China is a country ruled by law. All Chinese law enforcement and judicial activities are carried out based on facts and the law....
April 21, 2024
Drug prices
Copycats take bite out of AbbVie’s best-selling Humira drug
...Along with striking a co-brand deal with CVS to offer Hyrimoz at a discounted price of $1,315 a month, Sandoz has a higher list price version of the biosimilar, priced similarly to Humira at more than $6,000...
April 25, 2024
McKinsey
McKinsey faces US criminal investigation over opioid industry work
...McKinsey is facing a criminal investigation in the US over its work for opioid manufacturers, piling new pressure on a firm that has paid almost $1bn to settle civil claims that its advice fed an epidemic...
April 24, 2024
InterviewBristol-Myers Squibb Co
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
...“That’s what we do as a leadership team . . . is ensuring that we have back-up supply if there are any issues, regardless if it’s a regulatory issue or if it’s a natural disaster or if it’s some sort of...
April 25, 2024
Special ReportThe Americas’ Fastest Growing Companies
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
...person at a biotech fund with a shareholding in Vertex....
April 26, 2024
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...A blood test to detect amyloid beta fragments, removing the need for a $5,000 PET scan, is commercially available but not widely used....
April 22, 2024
News updates from April 16: Powell says inflation fight will take ‘longer than expected’; China GDP jumps 5.3%
UnitedHealth swings to loss after February cyber attack
...The health insurer said it recorded a net loss of around $1.53 a share in the three months to the end of March, compared with a profit of $5.95 a share during the same period last year....
April 16, 2024
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
News updates from April 5: US jobs growth outstrips forecasts in March; Thames Water parent company defaults on debt
Johnson & Johnson buys device maker Shockwave for $13bn
...Joaquin Duato, J&J’s chief executive, said the acquisition “provides a unique opportunity to accelerate our impact in cardiovascular intervention”....
April 5, 2024
Eli Lilly & Co
Eli Lilly weight-loss drug found to address sleep apnoea in trial
...Tirzepatide is part of a new class of weight-loss drugs, known as GLP-1s, which includes Novo Nordisk’s Wegovy and Ozempic drugs, that are projected to expand to a $100bn market by the end of the decade,...
April 17, 2024
News updates from April 17: UK inflation falls less than expected; Boeing engineer says safety concerns are ignored
Eli Lilly reports weight-loss drug ‘significantly’ reduces sleep apnoea
...Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage clinical trial, the pharmaceutical group said on Wednesday, adding to evidence that could encourage more...
April 17, 2024
Covid-19 vaccines
Hedge fund urges board shake-up at Novavax over struggling Covid vaccine
...The group had a market value of $600mn, as of market close on Friday....
April 15, 2024
Johnson & Johnson Co Inc
Johnson & Johnson buys device maker Shockwave for $13.1bn
...Last year, Shockwave completed a $147mn acquisition of Neovasc, which produces a device to treat refractory angina, another type of heart defect....
April 5, 2024
Letter
Letter: With LVT, there’s no need for crazy property levies
...Carol Wilcox Christchurch, Dorset...
April 19, 2024
Biotech
Weight loss biotech plans IPO as demand builds for anti-obesity treatments
...Aardvark Therapeutics, a US biotech group developing a weight loss pill, is planning to raise up to $200mn in an initial public offering as early as this summer, propelled by investor hype over anti-obesity...
March 29, 2024
News updates from April 2: Biden speaks with Xi, Fed’s Mester raises long-term rate outlook
Person in Texas infected with bird flu after exposure to dairy cattle
...A person in Texas has contracted the second known human case of H5N1 bird flu in the US, the Centers for Disease Control and Prevention said....
April 1, 2024
News updates from April 1: Israel accused of air strike on Iranian embassy; US manufacturing sector expands for first time since 2022
Person in Texas infected with bird flu after exposure to dairy cattle
...A person in Texas has contracted the second known human case of H5N1 bird flu in the US, the Centers for Disease Control and Prevention said....
April 1, 2024
Covid-19 vaccines
Moderna puts plans for African vaccine plant on hold
...The Boston-based company struck a deal with the Kenyan government a year ago to invest about $200mn in a facility that would produce up to 500mn vaccine shots a year....
April 11, 2024

Previous pagePage 1 of 177Next page